Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IDNA vs ETHSX overlap: 16% of top holdings shared

Bottom line

How much do IDNA and ETHSX overlap?

16% of their top holdings overlap by weight. 4 securities appear in both funds' top 25, making up 15.1% of IDNA's assets and 16.9% of ETHSX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

IDNAETHSX
Weight overlap (top 25)16%
Shared holdings4
Weight in shared holdings15.1%16.9%
Total positions6142
Expense ratio0.47%1.18%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings IDNA and ETHSX have in common

Holding% of IDNA% of ETHSXOverlap
Merck & Co., Inc.3.91%5.08%3.91%
Vertex Pharmaceuticals Incorporated3.87%3.38%3.38%
Roche Holding AG3.85%5.44%3.85%
Sanofi Sa3.46%2.95%2.95%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IDNA

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
  2. Bayer Aktiengesellschaft — 4.81%
  3. Twist Bioscience Corp — 4.79%
  4. Revolution Medicines, Inc. — 4.55%
  5. Regeneron Pharmaceuticals, Inc. — 4.35%
  6. Genmab A/s — 4.23%
  7. Incyte Corporation — 4.23%
  8. Moderna, Inc. — 4.19%
  9. Takeda Pharmaceutical Company Limited — 4.05%
  10. Ipsen Sa — 3.84%
  11. BioNTech SE — 3.73%
  12. Exelixis, Inc. — 3.65%
  13. Gsk Plc — 3.63%
  14. IDEAYA Biosciences Inc — 3.36%
  15. Immunitybio Inc — 3.07%

Only in ETHSX

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Bristol-Myers Squibb Co — 4.25%
  7. Gilead Sciences Inc — 3.34%
  8. Thermo Fisher Scientific Inc — 2.79%
  9. Intuitive Surgical Inc — 2.72%
  10. Stryker Corp — 2.21%
  11. Boston Scientific Corp — 2.18%
  12. Medtronic PLC — 1.80%
  13. Lonza Group AG — 1.77%
  14. Novo Nordisk A/S — 1.71%
  15. Abbott Laboratories — 1.65%

Asset mix

Asset typeIDNAETHSX
Stocks96.0%99.4%
Cash & short-term funds10.5%0.3%
Other3.8%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryIDNAETHSX
US70.2%69.4%
CH5.4%10.2%
DE8.5%—
GB3.7%7.8%
FR7.8%3.2%
JP6.0%—
DK4.2%2.9%
CN2.3%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do IDNA and ETHSX overlap?
About 16% by weight. 4 securities appear in both funds' top 25 holdings; they make up 15.1% of IDNA's assets and 16.9% of ETHSX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do IDNA and ETHSX have in common?
The largest shared holdings are Merck & Co., Inc., Roche Holding AG, Vertex Pharmaceuticals Incorporated, Sanofi Sa.
Should I own both IDNA and ETHSX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, IDNA or ETHSX?
IDNA is broader, with 61 positions versus 42 for ETHSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.